Fycompa Patient Assistance Program

Fycompa is a prescription medication approved as monotherapy or adjunctive therapy for partial-onset seizures in patients age 4 years and older.  Fycompa is also approved as adjunctive therapy for primary generalized tonic-clonic seizures in patients age 12 years and older. Its active ingredient, perampanel, works in the brain to quiet the overexcited nerve activity that sets a seizure in motion.

Epilepsy asks you to live with a certain unpredictability, never fully certain when the next seizure might come. Medication that keeps that in check can give a good deal of steadiness back, but only when it’s taken without gaps. If the cost has grown difficult, whether your insurance falls short or you carry no coverage at all, a Patient Assistance Program (PAP) may help you stay on it, depending on how your situation fits the program.

Apply for Assistance
Start a Patient Assistance Application for Fycompa

How Prescription Details Affect Fycompa Assistance Eligibility

a package with scattered tablets on a blue background

About the Fycompa Patient Assistance Program

A program like this comes from the company behind the medicine, meant to reach patients who depend on it but can’t carry the cost by themselves. Fycompa’s is set up for people with epilepsy whose insurance leaves the price out of reach.

Getting started calls for a prescription from the neurologist or doctor managing your epilepsy, together with paperwork showing your household income over the past year.

Once those reach us, the work becomes ours. We gather the clinical details the manufacturer needs from your doctor, put your income records into the program’s format, and send the whole application through together. We follow the review as it moves along, and once you’re approved, your Fycompa arrives for continued treatment. Meeting every requirement isn’t a guarantee on its own, since the manufacturer decides each application individually.

How Fycompa Works

A seizure happens when nerve cells in the brain fire in a sudden, uncontrolled surge, overwhelming the normal signals that keep activity orderly. Much of that overexcitement runs through a messenger called glutamate.

Perampanel works by blocking the receptor glutamate acts on.

By getting in the way of that signal, the medication dampens the runaway activity that drives a seizure, which for many people means fewer seizures and longer stretches of stability between them. It’s designed for steady, ongoing control rather than stopping a seizure as it happens.

You take Fycompa once a day at bedtime, which helps manage the drowsiness it can cause. Because it builds up slowly, your doctor will usually raise the dose in small steps, and staying consistent is what keeps it working.

Side Effects and Safety Information

Since Fycompa acts on the brain, its most common effects touch balance, alertness, and mood. Many emerge early and ease as your body adjusts. They can include:

  • Dizziness or unsteadiness
  • Drowsiness or fatigue
  • Headache or nausea

Because of the dizziness and drowsiness, take care with driving or anything requiring full alertness until you know how it affects you.

Fycompa carries a boxed warning for serious mood and behavior changes, including irritability, aggression, anger, anxiety, or thoughts of harming yourself or others, sometimes appearing quickly after starting or after a dose increase. Any such change deserves prompt attention from your doctor and the people close to you. Stopping the medication suddenly can bring seizures back, so any change to your dose should happen gradually under your doctor’s guidance, and alcohol is best avoided since it can deepen both the drowsiness and the mood effects.

Fycompa is a Schedule III controlled substance because of abuse and dependence potential.

What Happens Next?
  • Step 1 – Submit Application

    Provide basic prescription and household information to begin the application process.

  • Step 2 – Application Review

    Information is reviewed and submitted to appropriate Patient Assistance Programs.

  • Step 3 – Program Decision

    Final eligibility decisions are made by each program. Additional steps or renewals may be required.

24 Hour Response
PHN will contact you within 24 hours to discuss your situation and help identify appropriate next steps for the application process.
8 Years
Supporting Patients
10000+
Applications Assisted
Nationwide
Application Support

How it applies / Eligibility

To qualify, you’ll need to meet all of the following:

  • Single patients earning less than $40,000 per year
  • Couples making under $60,000 combined yearly
  • Households with three or more people bringing in below $100,000 annually
  • Active Fycompa prescription from your healthcare provider
  • Proof of U.S. citizenship or legal residency
  • Limited or inadequate prescription drug coverage for Fycompa

Income usually carries the most weight, though the review considers your wider circumstances, and clearing every line above still leaves the final decision to the manufacturer.

Fycompa patient assistance eligibility

Frequently asked questions (FAQ`s)

What happens if my application gets denied?

A denial comes with its reason in writing. Often it’s income above the limit, coverage the manufacturer counts as sufficient, or an application that arrived missing something. None of that is final, so a change in your finances or the missing document opens the way to apply again.

How do program renewals work?

Count on renewing once a year. Before the deadline, you send fresh income records and your doctor’s confirmation that Fycompa is still needed. If those don’t arrive in time, the enrollment lapses.

What documents do I need to apply?

Four things: proof of citizenship or legal residency, a year of household income records, a current Fycompa prescription from a licensed provider, and a summary of the drug coverage you hold.

How does Patient Help Network assist with applications?

We handle the enrollment from beginning to end, confirming you meet the standards, organizing your paperwork, coordinating with your care team, and delivering the manufacturer a finished application.

Is there a generic version of Fycompa available?

A generic form of perampanel has been approved, though availability and coverage can vary. Patients approved through the program receive brand-name Fycompa.

How long does the manufacturer review usually take?

There’s no set timeline. It depends on the manufacturer’s workload and how many people are reviewing applications. We stay in touch and pass along updates as they come.

Can eligibility requirements change over time?

They can shift. A manufacturer might adjust an income limit or reconsider what counts as adequate coverage. We follow the programs and reach out when a change affects where you stand.

Reviews